SelectQuote

SelectQuote reported fiscal 2026 revenue of $1.62 billion (up 6%) and adjusted EBITDA of $109 million, with operating cash flow improving by $44 million year over year. For fiscal 2027 the company expects revenue to decline to $1.35–1.45 billion while targeting more than $60 million in operating cash flow, about $50 million in free cash flow and over $30 million of annualized cost savings. Healthcare Services grew 14% to $845 million in fiscal 2026 and, despite a projected 10–15% revenue decline next year from policy and reimbursement headwinds, management expects significant margin expansion driven by greater use of its Kansas pharmacy facility. SelectQuote will focus on cash generation, deleveraging and efficiency rather than top-line growth in fiscal 2027. » More on finance.yahoo.com

SelectQuote reported an adjusted loss of $0.19 per share and revenue of $321.7 million for Q4 2026, both below consensus expectations, after which the stock fell about 16% in premarket trading. For fiscal 2026, revenue rose to $1.62 billion and adjusted EBITDA to $109 million, exceeding the annual guidance. Management is shifting its 2027 focus from growth to cash flow, margin improvement and debt reduction, and expects revenue of $1.35–1.45 billion and adjusted EBITDA of $90–115 million. At the same time, SelectQuote plans annual cost savings of more than $30 million and forecasts operating cash flow for 2027 to rise to over $60 million. » More on de.investing.com

SelectQuote will report results for the quarter ended June 30, 2026, on August 25, 2026. Four analysts forecast an average EPS of -$0.165 per share versus -$0.020 in the year-ago quarter, while revenue is expected on average to rise to $353.4 million (up 2.42% from $345.1 million). For the just-ended fiscal year, analysts see an average EPS of -$0.028 and revenue of about $1.65 billion versus $1.53 billion a year earlier. » More on finanzen.net